Head and neck cancer
A109 – A118
- A109: Comparative analysis of tomotherapy versus field in field complex forward planned conformal technique versus 2 phase conformal technique in the radical radiotherapy treatment of squamous cell carcinoma of the head and neck
- A110: Phase II study of pegylated liposomal doxorubicin Caelyx chemotherapy as palliative systemic treatment in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma
- A111: Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre
- A112: Dosimetry for radioiodine treatment of differentiated thyroid cancer
- A113: Host-viral epigenetic interactions in HPV16-mediated oropharyngeal cancer
- A114: Comparative analysis of TCP, NTCP, conformity index and risk of second malignancies when radical radiotherapy is delivered using three different techniques for the treatment of head and neck squamous cell carcinomas
- A115: Primary invasive ductal carcinoma of the parotid gland: A case report, literature review and optimal management plan for this rare condition
- A116: Genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD
- A117: Return to work in head and neck cancer patients after radical curative therapy
- A118: Return to work after therapy for thyroid cancer with curative intent
